Vertos Medical Inc.'s Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild(R)
3/12/2010 11:02:19 AM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild* for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability. The data also confirmed mild’s safety, with no reports of patient complications related to the procedure or the devices.